OpenLegislation

Division 5.9 Medical dataF1

United Kingdom

Original text. Later amendments are not shown.

Where available, and without prejudice to the provisions of F2the EU-derived domestic legislation which transposed Article 10 of Council Directive 98/24/EC, practical data and information relevant to the recognition of the symptoms of poisoning, and on the effectiveness of first aid and therapeutic measures have to be submitted. More specific references to the investigation for antidotal pharmacology or safety pharmacology using animals shall be provided. Where relevant, the effectiveness of potential antagonists to poisoning, shall be investigated and reported.

Data and information relevant to the effects of human exposure, where available and of the necessary quality, are of particular value, in confirming the validity of extrapolations made and conclusions reached with respect to target organs, dose-response relationships, and the reversibility of toxic effects. Such data can be generated following accidental or occupational exposure.

  1. 5.9.1Medicinal surveillance on manufacturing plant personnel
  2. 5.9.2Direct observation, e.g. clinical cases and poisoning incidents
  3. 5.9.3Observations on exposure of the general population and epidemiological studies if appropriate
  4. 5.9.4Diagnosis of poisoning (determination of active substance, metabolites), specific signs of poisoning, clinical tests
  5. 5.9.5Proposed treatment: first aid measures, antidotes, medical treatment
  6. 5.9.6Expected effects of poisoning

Annotations

Textual amendments

F1

Repealed (subject to transitional measures in Arts. 3, 4) by Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market Text with EEA relevance.

F2

Words in Annex Pt. A point 5.9 inserted (31.12.2020) by The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), regs. 1(1), 16(5)(b)(vi); 2020 c. 1, Sch. 5 para. 1(1)